Alnylam Pharmaceuticals (ALNY) Long-Term Debt Issuances (2020 - 2022)
Historic Long-Term Debt Issuances for Alnylam Pharmaceuticals (ALNY) over the last 3 years, with Q4 2022 value amounting to -$777000.0.
- Alnylam Pharmaceuticals' Long-Term Debt Issuances changed N/A to -$777000.0 in Q4 2022 from the same period last year, while for Dec 2024 it was $1.0 billion, marking a year-over-year change of 0.0%. This contributed to the annual value of $1.0 billion for FY2022, which is N/A changed from last year.
- As of Q4 2022, Alnylam Pharmaceuticals' Long-Term Debt Issuances stood at -$777000.0.
- Alnylam Pharmaceuticals' Long-Term Debt Issuances' 5-year high stood at $1.0 billion during Q3 2022, with a 5-year trough of -$250.0 million in Q3 2021.
- In the last 3 years, Alnylam Pharmaceuticals' Long-Term Debt Issuances had a median value of $99.6 million in 2020 and averaged $241.5 million.
- Data for Alnylam Pharmaceuticals' Long-Term Debt Issuances shows a peak YoY increase of 50675.52% (in 2022) and a maximum YoY decrease of 50675.52% (in 2022) over the last 5 years.
- Quarter analysis of 3 years shows Alnylam Pharmaceuticals' Long-Term Debt Issuances stood at $200.0 million in 2020, then tumbled by 225.0% to -$250.0 million in 2021, then skyrocketed by 99.69% to -$777000.0 in 2022.
- Its Long-Term Debt Issuances stands at -$777000.0 for Q4 2022, versus $1.0 billion for Q3 2022 and -$250.0 million for Q3 2021.